Algo version: 0.98b
Maxigen Biotech Inc. is listed at the TAI Exchange
Maxigen Biotech Inc. [1783.TW]
TAI Sector: Healthcare Industry:Medical Instruments & Supplies

Is Maxigen Biotech Inc. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Maxigen Biotech Inc. pays dividends. Last time was Friday 16th of August 2024 where the investors holding the stock on Tuesday 23rd of July 2024 were paid TWD0.99873 per share. Over the last 6 times between 2018 and 2024, Maxigen Biotech Inc. has paid TWD3.84031 with an average of TWD0.64 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Maxigen Biotech Inc. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was TWD22.29, you would have made a profit of TWD23.21 per share or 104.13%

Yes, the average daily trading liquidity for Maxigen Biotech Inc. is TWD407 314 thousand. You should therefore be able to get in and out of your positions relatively fast.

Maxigen Biotech Inc. has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 4 017.82, the company's ability to pay off the debt is good. Maxigen Biotech Inc. has a very good net profit margin of 24.71% and should have very high tolerances against inflation.

We have calculated the inflation risk for Maxigen Biotech Inc. to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.